Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study
Carregando...
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2018
Editora
ASSOC BRASILEIRA PSIQUIATRIA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA BRASILEIRA DE PSIQUIATRIA, v.40, n.3, p.309-311, 2018
Resumo
Objective: Theta-burst stimulation (TBS) modulates synaptic plasticity more efficiently than standard repetitive transcranial magnetic stimulation delivery and may be a promising modality for neuropsychiatric disorders such as autism spectrum disorder (ASD). At present there are few effective interventions for prefrontal cortex dysfunction in ASD. We report on an open-label, pilot study of intermittent TBS (iTBS) to target executive function deficits and restricted, repetitive behaviors in male children and adolescents with ASD. Methods: Ten right-handed, male participants, aged 9-17 years with ASD were enrolled in an open-label trial of iTBS treatment. Fifteen sessions of neuronavigated iTBS at 100% motor threshold targeting the right dorsolateral prefrontal cortex were delivered over 3 weeks. Results: Parent report scores on the Repetitive Behavior Scale Revised and the Yale-Brown Obsessive Compulsive Scale demonstrated improvements with iTBS treatment. Participants demonstrated improvements in perseverative errors on the Wisconsin Card Sorting Test and total time for the Stroop test. The iTBS treatments were well tolerated with no serious adverse effects. Conclusion: These preliminary results suggest that further controlled interventional studies of iTBS for ASD are warranted.
Palavras-chave
Autism spectrum disorder, intermittent theta burst stimulation, noninvasive brain stimulation, theta-burst stimulation, repetitive transcranial magnetic stimulation
Referências
- Ameis SH, 2017, J CHILD ADOL PSYCHOP, V27, P413, DOI 10.1089/cap.2016.0146
- Desarkar P, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00124
- Enticott PG, 2013, NEUROPHARMACOLOGY, V68, P202, DOI 10.1016/j.neuropharm.2012.06.017
- GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
- Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033
- Jung NH, 2013, DEV MED CHILD NEUROL, V55, P83, DOI 10.1111/dmcn.12012
- Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021
- Lam KSL, 2007, J AUTISM DEV DISORD, V37, P855, DOI 10.1007/s10803-006-0213-z
- Lord C, 2015, ANNU REV CLIN PSYCHO, V11, P53, DOI 10.1146/annurev-clinpsy-032814-112745
- Masi A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.143
- Monchi O, 2001, J NEUROSCI, V21, P7733
- Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014
- Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15
- Wechsler D., WECHSLER INTELLIGENC
- Williams K, 2010, COCHRANE DB SYST REV, V8, DOI 10.1002/14651858